
See A Flying Humanoid Robot Achieve Liftoff For The First Time
iRonCub lifts off with the help of four jet engines, two mounted on its arms and two on a jetpack ... More attached to its back.
After two years of trial, error and persistence, an Italian robotics team finally watched as its humanoid bot did what it was designed to do — take to the air.
As the below video shows, the jet-powered robot named iRonCub (yep, that's an Iron Man reference) lifted off the ground about 1.5 feet while maintaining its stability. It's still early days in the prototype's flying career, but iRonCub's creators say its first flight this spring could pave the way for humanoid robots that switch between terrestrial navigation and aerial mobility when operating in extreme terrain and environments devastated by natural disasters.
'This first flight has been a long journey for us,' Daniele Pucci, director of artificial and mechanical intelligence at the Italian Institute of Technology, said in an email. Pucci co-authored a new research paper in the open-access journal Open Engineering detailing how the team modeled and controlled the robot's aerodynamics and validated their approach through wind tunnel experiments in which iRonCub hovered and performed controlled flight maneuvers amid high-speed gusts and extreme temperatures.
In wind tunnel tests at the DAER Aerodynamics Laboratory of Polytechnic of Milan, iRonCub stayed ... More stable amid high-speed, turbulent gusts.
Researchers worldwide are already focusing on multimodal robots that can adjust to their environments and access sites too hazardous or difficult for humans to reach. So what's the benefit of equipping such robots with human-like arms, legs and hands?
In emergency and disaster scenarios, many critical access points are built with human ergonomics in mind, including doors, gas valves, ladders, switches and handles, Pucci and fellow researchers Davidi Gorbani and Antonello Paolino said in a joint written response to my questions. 'A humanoid robot, therefore, is inherently well-suited to interact with these human-centric systems, navigating staircases, narrow corridors, or uneven terrains, and directly manipulating objects designed for human hands.'
iRonCub evolved from iCub, an earlier research-grade robot out of the Italian Institute of Technology that was designed to help develop and test embodied AI algorithms, and which currently is available for sale. iCub's flying cousin is equipped with AI-powered control systems — developed in collaboration with Gianluca Iaccarino's mechanical engineering group at Stanford University — and lifts off with the help of four jet engines, two mounted on its arms and two on a jetpack attached to its back.
With jet engines attached, the robot weighs around 154 pounds. To protect it from the force and heat produced by the engines, iCub got upgraded with a titanium spine and heat-resistant covers.
While the video shows iRonCub attached to a harness for safety and remaining comfortably close to terra firma, reaching this milestone posed significant design and engineering challenges. Its movable limbs complicate the aerodynamics, and gases emitted from the wind turbines exceed 1,200 degrees and flow at nearly the speed of sound.
'Controlling these robots in flight is fascinating yet dangerous, and there's no room for improvisation,' Pucci, Gorbani and Paolino said. 'The complexity of safely managing combustion, heat dissipation and high-speed airflow demands meticulous, multidisciplinary co-design strategies, simultaneously optimizing the robot's physical shape, materials, control algorithms and propulsion system placement.'
Next up for iRonCub will be further flight tests, some at the Genoa Airport, which is setting up a dedicated area for robo-flights where it can hopefully practice untethered liftoffs. The robot may not be Tony Stark yet, but the team envisions a day when we will see it flying over obstacles like floods and fires and landing safely amid unstable debris — like a real-life superhero.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
I found a bacteria-eating virus in my loo - could it save your life?
I'm on the hunt for a microbial saviour – a type of virus that can treat infections rather than cause them. We all know the viral bad guys – Covid, flu, norovirus, herpes, chicken pox, measles… the list goes on. But there's a type of virus that's not interested in infiltrating our bodies, instead it preys on bacteria. They're known as bacteria eaters, or bacteriophage, or commonly as phage. Capturing them could give us new ways of treating infections, including superbugs that are becoming incurable. So, how to catch a killer? I've been promised it's surprisingly easy. The team at the Phage Collection Project sent me some vials to collect samples, along with a pair of gloves. All I need to do is hunt for some dirty water, the dirtier the better, dip the vials in and screw on the lid. I tried a couple of ponds, the juice from a worm-composting bin and then I needed my dirtiest sample. I didn't flush the toilet after a poo and left it for a couple of hours. I pop on a glove and hold my breath as I go in for the final sample. Strict hygiene instructions, including vigorous hand-washing, were followed, at all times. The vials were packaged up for collection and then three days later I headed off to the University of Southampton to see what was inside. "They were a bit dirty when I received them," phage scientist Michelle Lin tells me as we don our blue lab-coats and matching gloves to go into the Containment Level 2 microbiology laboratory. We grab my samples from the fridge, which look much clearer now they have been filtered of any… debris. "It's fine, it's needed," Michelle, who had the unpleasant job, reassures me. Filtering is the first step in looking for phage, next they get served dinner – a cocktail of yummy bacteria - to help them grow in number. Now comes the really cool bit – finding a useful phage. The scientists have been working with the local hospital to collect bacteria from patients with troublesome infections. Michelle grabs a petri dish that's growing bacteria from a patient with a painful, urinary tract infection that keeps coming back. And to my amazement – one of the phage I collected from my toilet was able to kill this infection in the lab. "The way to see that the phage has infected bacteria is you get these zones where the bacteria are not growing and that's because they've been killed by the phage," says Michelle. You can see the leopard print pattern in the petri dish where the phage have been making light work of a bacterial infection that modern medicine was struggling to shift. "As crazy as it sounds, well done to the toilet sample," says Michelle with great delight. And when I was offered the chance to name the phage, well of course it's the Gallagher-phage. "Sounds amazing to me," says Michelle. So far this is all good fun in the laboratory, but could my phage ever be given to a patient? "Yes and I hope so," says associate professor Dr Franklin Nobrega as we look at images of my phage captured with an electron microscope. "Your phage, already in just 24 hours, we were able to get in a high concentration and able to be a very good killer, which means this is very promising for patients, so thank you," said Dr Nobrega. Phage remind me of a moon lander – a big capsule on spindly legs – just instead of landing on the surface of the moon they use their legs to select their victim. They then hijack the bacteria and transform it into a mass-production factory for more phage, which burst out of their host, killing it in the process. There are pros and cons to phage. They reproduce as they go along so you don't need constant doses like you would with drugs. They are also very picky eaters. You need a precise match between phage and the strain of bacteria you're trying to treat whereas antibiotics tend to kill everything good and bad. So it is harder to find the right phage, but if you do it comes with fewer side effects. Dr Nobrega tells me infected wounds are a "very good application" for phage because you can apply them directly to the injury, but they can also be inhaled via a nebuliser to treat lung infections or to target urinary tract infections "which is our target currently". Phage science may sound new and exciting, but it is actually a century old idea stemming from the discoveries of Felix d'Hérelle and Frederick Twort in the 1910s. Bacteriophage therapy was a branch of medicine and the idea was compelling. Even as late as the 1940s there was an active pharmaceutical industry in western countries trying to produce phage-therapy to defeat bacterial infections. However, it was rapidly eclipsed by the wonder-drug of the 20th century. "Antibiotics were working so well that most people said 'why bother'," says Dr Nobrega. Work on phage therapy continued in places like Georgia and there are individual accounts of it working wonders; but there hasn't been the same depth of medical research and clinical trials as there have for drugs. But just as the initial success of antibiotics suppressed phage research, the failure of antibiotics is reigniting excitement at their potential. More than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's known as the "silent pandemic". By 2050, that figure is projected to reach 10 million a year. This "antibiotic apocalypse" would mean common infections could kill again and undermine modern medicine. The drugs are also used to make organ transplants, open surgery and chemotherapy possible. "The predictions around antibiotic resistance are very frightening, but the reality is we're seeing it now and it's only going to get worse," says Prof Paul Elkington, the director of the institute for medical innovation at the University of Southampton. He is also a doctor with a speciality in lung medicine and is already at the point where - after a year of treatment and turning to ever more toxic and less effective antibiotics - "in the end you have to have a conversation [and say] 'we can't treat this infection, we're really sorry'". He says we can't rely solely on antibiotics in the future and phage are a potential alternative. But he warns the steps needed to get from the laboratory and into patients are "uncharted". Things are changing. Phage therapy is available in the UK on compassionate grounds when other treatments have failed. And the drugs regulator – The Medicines and Healthcare products Regulatory Agency – has published its first official rules to support the development of phage therapy. "If one looks 15-20 years into the future, with the emerging methodologies, it's going to be possible for them to be much more widely available and for doctors to prescribe phage instead of antibiotics for some infections," says Prof Elkington. If you want to see if you can find a friendly virus too then The Phage Collection Project are launching their new sampling kits at the Summer Science Exhibition taking place this week at the Royal Society and through their website. "Antimicrobial resistance is something that could affect all of us," says Esme Brinsden from the Phage Collection Project, "when the public get involved they may just find the next phage that can help treat and save a patient's life". Photography by the BBC's Emma Lynch
Yahoo
3 hours ago
- Yahoo
Meta Faces Billion-Dollar Threat: EU Warns of Daily Fines Starting June 2025
Meta (NASDAQ:META) just got another regulatory migraine from Brussels. On Friday, the European Commission made it loud and clear: if Meta's latest tweaks to its pay-or-consent model don't pass muster under the Digital Markets Act (DMA), the company could be staring down daily fines of up to 5% of global revenuestarting June 27, 2025. This comes on the heels of a 200 million ($234 million) penalty in April, after regulators ruled that Meta's original model, which launched in November 2023, breached the EU's new gatekeeper law. While Meta did update the model to reduce personal data usage for ad targeting post-November 2024, the Commission says those adjustments might still fall short. Warning! GuruFocus has detected 6 Warning Sign with META. At the core of the standoff is Meta's two-option system for Facebook and Instagram users: either pay for an ad-free experience, or use the service for free and consent to being tracked for personalized ads. Meta says this model is both common and compliant. The Commission isn't convinced. A spokesperson said the current form of the model only reflects limited changes and hasn't yet met the compliance yardstick defined in its prior decision. In other words, regulators aren't buying ityet. The message? Fix it, or pay up. The EU isn't bluffing either. These potential daily fines would escalate pressure on Meta at a time when tech giants are already under fire across multiple jurisdictions. Meta, unsurprisingly, is pushing back. Hard. The company claims it's being singled out. A user choice between a subscription or a free, ad-supported service is standard across Europeexcept when it's Meta offering it, a spokesperson said. The company insists its model goes beyond what's required. The Commission quickly shot down the discrimination charge, reiterating that the DMA applies to any large digital player operating in the EUregardless of origin. Bottom line: Meta's showdown with Brussels isn't cooling off. Investors should watch this one closelybecause the cost of staying non-compliant could soon show up in Meta's margins. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Meta Faces Billion-Dollar Threat: EU Warns of Daily Fines Starting June 2025
Meta (NASDAQ:META) just got another regulatory migraine from Brussels. On Friday, the European Commission made it loud and clear: if Meta's latest tweaks to its pay-or-consent model don't pass muster under the Digital Markets Act (DMA), the company could be staring down daily fines of up to 5% of global revenuestarting June 27, 2025. This comes on the heels of a 200 million ($234 million) penalty in April, after regulators ruled that Meta's original model, which launched in November 2023, breached the EU's new gatekeeper law. While Meta did update the model to reduce personal data usage for ad targeting post-November 2024, the Commission says those adjustments might still fall short. Warning! GuruFocus has detected 6 Warning Sign with META. At the core of the standoff is Meta's two-option system for Facebook and Instagram users: either pay for an ad-free experience, or use the service for free and consent to being tracked for personalized ads. Meta says this model is both common and compliant. The Commission isn't convinced. A spokesperson said the current form of the model only reflects limited changes and hasn't yet met the compliance yardstick defined in its prior decision. In other words, regulators aren't buying ityet. The message? Fix it, or pay up. The EU isn't bluffing either. These potential daily fines would escalate pressure on Meta at a time when tech giants are already under fire across multiple jurisdictions. Meta, unsurprisingly, is pushing back. Hard. The company claims it's being singled out. A user choice between a subscription or a free, ad-supported service is standard across Europeexcept when it's Meta offering it, a spokesperson said. The company insists its model goes beyond what's required. The Commission quickly shot down the discrimination charge, reiterating that the DMA applies to any large digital player operating in the EUregardless of origin. Bottom line: Meta's showdown with Brussels isn't cooling off. Investors should watch this one closelybecause the cost of staying non-compliant could soon show up in Meta's margins. This article first appeared on GuruFocus. Sign in to access your portfolio